Loading
Ascentage Pharma Group International Stock: price and insider trades · United States
US·Mcap US$1.4B
Ascentage Pharma Group International: what insiders have been doing
Ascentage Pharma Group International is a listed company. Its insiders report their share dealings to SEC (Form 4). Over the twelve months to 18 October 2026, 4 filings were filed, from 2 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 4 filings, this issuer sits below that mark.
Insider buying of Ascentage Pharma Group International has been absent for the past year. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate Ascentage Pharma Group International Strong Buy (bullish), based on 8 analysts. Average price target: US$45.50.
Fundamental score
Ranked 20,461 of 23,476 companies
25.0
score / 100
Value2
Quality48
FCF yld-84%
Earn yld-87%
EV/EBITDA·
ROE-237%
Gross mgn91%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$15.31
Analyst consensus
8 analystsStrong buy
US$33.00Target US$45.50(+197%)US$55.00
Income statement
RevenueUS$574.1M
Gross profitUS$525.2M91% margin
EBITDA-US$1.1B-191% margin
Net income-US$1.2B-228.5% margin
Valuation
PER (forward)-20.0x
P/Book17.2x
Beta0.66
Balance sheet & cash
Market capUS$1.4B
Total debtUS$2B
Free Cash Flow-US$1.2B
Debt / Equity370%
Profitability & ownership
ROE-236.6%
ROA-28.0%
% insiders0.0%
% institutions0.0%
Last declaration on 22 May 2026
Declarations4 total
95,575 shares0Ordinary SharesSEC:0001213900-26-060585:0
92,746 shares0Ordinary SharesSEC:0001213900-26-060585:1
92,746 shares0Ordinary SharesSEC:0001213900-26-060632:0
95,575 shares0Ordinary SharesSEC:0001213900-26-060632:1
4 of 4 declarations
About Ascentage Pharma Group International
Ascentage Pharma Group International is a company focused on developing innovative pharmaceutical solutions. It operates on the XNAS stock market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
